Washington, D.C.-based Children’s National Hospital administered Zynteglo, a $2.8 million gene therapy, to its first pediatric patient with the help of Clearway Health.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Children's National Hospital taps Clearway to deliver $2.8M gene therapy
